Prochlorperazine and Haemoglobin abnormal - a phase IV clinical study of FDA data

Summary:

Haemoglobin abnormal is reported as a side effect among people who take Prochlorperazine (prochlorperazine), especially for people who are female, 60+ old, also take Lorazepam, and have Carcinoid tumor.

The phase IV clinical study analyzes which people have Haemoglobin abnormal when taking Prochlorperazine. It is created by eHealthMe based on reports of 14,440 people who have side effects when taking Prochlorperazine from the FDA, and is updated regularly.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.

What is Haemoglobin abnormal?

Haemoglobin abnormal is found to be associated with 614 drugs and 1,009 conditions by eHealthMe. Check the latest studies of Haemoglobin abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

14,440 people reported to have side effects when taking Prochlorperazine.
Among them, 15 people (0.1%) have Haemoglobin abnormal.

Could Prochlorperazine cause Haemoglobin abnormal?

Among these 15 people:

What is the gender of people who have Haemoglobin abnormal when taking Prochlorperazine? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Haemoglobin abnormal when taking Prochlorperazine? *

What are other drugs people take besides Prochlorperazine? *

What are other side effects people have besides Haemoglobin abnormal? *

Platelet Count Abnormal: 6 people, 40.00%
Diarrhea: 5 people, 33.33%
Oedema Peripheral (superficial swelling): 5 people, 33.33%
Weakness: 4 people, 26.67%
Bradycardia (abnormally slow heart action): 4 people, 26.67%
Rashes (redness): 4 people, 26.67%
Scab (a hard coating on the skin formed during the wound healing): 3 people, 20.00%
Body Temperature Decreased: 3 people, 20.00%
Metastases To Liver (cancer spreads to liver): 3 people, 20.00%
Blood Pressure Systolic Increased: 3 people, 20.00%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 20.00%
Carcinoid Tumor: 3 people, 20.00%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
Renal Cell Carcinoma (a kidney cancer): 1 person, 6.67%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 6.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Prochlorperazine and have Haemoglobin abnormal?

- Check whether Haemoglobin abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prochlorperazine:

Prochlorperazine (14,632 reports)

Browse all side effects of Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (614 drugs)

Browse all the conditions that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (1,009 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prochlorperazine (the active ingredients of Prochlorperazine) and Prochlorperazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.